Moreover recent studies have shown that smokers have lower risk of contracting COVID-19, and one explanation could be the interference between the nicotine which downregulates the ACE2 receptor.
As no approved therapeutics exists to treat COVID-19, the disease associated to SARS-Cov-2, there is an urgent need to propose molecules that could quickly enter into clinics.